Oxalic Acid

Oxalic Acid

SCHEMBL7438526

COc1ccc2c(c1)c(CCN)cn2C(=O)c1ccccc1.O=C(O)C(=O)O

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.73
AKR1C3 P42330 11/20 0.59
AKR1C2 P52895 5/20 0.59
AKR1C4 P17516 1/20 0.59
PTGS1 P23219 1/20 0.59
ADRB2 P07550 1/20 0.56
HTR1A P08908 1/20 0.53
HTR1D P28221 1/20 0.53
HTR1B P28222 1/20 0.53
HTR1F P30939 1/20 0.53
HTR7 P34969 1/20 0.53
MTNR1A P48039 1/20 0.51
HSP90AA1 P07900 1/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3029516 0.86 HTR6 (0.76) HTR6AKR1C3AKR1C2AKR1C4PTGS1
SCHEMBL3025302 0.84 HTR6 (0.73) HTR6AKR1C3AKR1C2AKR1C4PTGS1
SCHEMBL30485865 0.84 HTR6 (1.00) HTR6AKR1C3AKR1C2AKR1C4PTGS1
SCHEMBL5497004 0.84 HTR6 (1.00) HTR6AKR1C3AKR1C2AKR1C4PTGS1
SCHEMBL13240305 0.84 HTR6 (0.73) HTR6AKR1C3AKR1C2AKR1C4PTGS1
SCHEMBL18133072 0.84 AKR1C3 (0.81) HTR6AKR1C3AKR1C2AKR1C4PTGS1
SCHEMBL1971963 0.82 MTNR1A (0.72) HTR6AKR1C3AKR1C2AKR1C4PTGS1
Oxalic Acid SCHEMBL27614859 0.80 ADRB2 (0.62) HTR6AKR1C3AKR1C2ADRB2HTR1A
SCHEMBL7438537 0.80 HTR6 (0.61) HTR6AKR1C3AKR1C2AKR1C4PTGS1
SCHEMBL28924882 0.80 ALOX5 (0.59) HTR6AKR1C3AKR1C2AKR1C4PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187805-B1 TREATING CONDITION FOR WHICH SELECTIVE AGONISM OR ANTAGONISM OF 5-HT-6 RECEPTORS IS INDICATED BY ADMINISTERING COMPOUNDS SUCH AS N,N-DIMETHYL 2-(1-(BENZENESULPHONYL)-5-METHOXY-1H-INDOL-3-YL)ETHYLAMINE MERCK SHARP & DOHME LTD. (GB) 2001-02-13 US disclosed